What is NAYA Biosciences, Inc. (NAYA) stock price today?

NAYA Biosciences, Inc. (NAYA) is currently trading at $2.20, up 8.37% today.

What is NAYA P/E ratio?

NAYA Biosciences, Inc.'s P/E ratio is -0.07. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is NAYA return on equity (ROE)?

NAYA Biosciences, Inc.'s return on equity (ROE) is -133.37%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is NAYA Biosciences, Inc.'s market cap?

NAYA Biosciences, Inc. has a market capitalization of $1.47M.

NASDAQ · Medical - Devices

NAYA Biosciences, Inc. (NAYA) Stock

$2.20 +8.37% NASDAQ: NAYA Healthcare

INVO Bioscience operates as a medical device company, focusing on the development and provision of tools and solutions for diagnosing infertility. Their primary innovation is INVOcell, a unique reproductive technology designed to allow both fertilization and the early development of an embryo to happen inside the woman's own body.

Valuation

Metric	Value
Price	$2.20
Market Cap	$1.47M
P/E Ratio	-0.07
P/B Ratio	0.05
P/S Ratio	0.22
EPS (TTM)	$-30.19
52-Week High	$17.04
52-Week Low	$1.38
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-133.37%
ROA	-19.58%
ROCE	-28.49%
Gross Margin	44.00%
Operating Margin	-124.40%
Net Margin	-139.25%
Debt/Equity	0.78
Current Ratio	0.07

Annual Financials (USD)

Metric	2020	2021	2022	2023	2024
Revenue	$1.0M	$4.0M	$1.0M	$3.0M	$7.0M
Operating Profit	$-6.0M	$-5.0M	$-11.0M	$-7.0M	$-8.0M
Net Profit	$-8.0M	$-7.0M	$-11.0M	$-8.0M	$-9.0M
EPS	$-15.21	$-6.26	$-8.99	$-5.13	$-30.19
Op Margin	-531.7%	-125.4%	-1292.5%	-224.0%	-124.4%

Balance Sheet (USD)

Metric	2020	2021	2022	2023	2024
Total Assets	$11.0M	$10.0M	$4.0M	$19.0M	$46.0M
Total Liabilities	$5.0M	$3.0M	$5.0M	$18.0M	$34.0M
Cash	$10.0M	$6.0M	$0	$0	$1.0M
Borrowings	$1.0M	$2.0M	$2.0M	$6.0M	$10.0M

Latest News

Nayax to Report 2026 Q2 Earnings on August 10, 2026 GlobeNewswire · Jul 21, 2026 Nayax Says Systems Restored After Cybersecurity Incident, Rejects Extortion Demand MT Newswires · Jul 14, 2026 Nayax: information security incident update GlobeNewswire · Jul 14, 2026 Nayax (NYAX) Earns Higher Price Target as Growth Story Builds Insider Monkey · Jul 8, 2026 Nayax Adds AI Layer to its MoMa Mobile App for Vending and Self-Service Operators GlobeNewswire · Jul 3, 2026

Cash Flow (USD)

Metric	2020	2021	2022	2023	2024
Operating Cash Flow	$-5.0M	$-6.0M	$-7.0M	$-5.0M	$-3.0M
Investing Cash Flow	$0	$-3.0M	$0	$-3.0M	$0
Financing Cash Flow	$0	$0	$0	$0	$1.0M
Net Cash Flow	$9.0M	$-4.0M	$-6.0M	$0	$1.0M
Free Cash Flow	$-5.0M	$-6.0M	$-7.0M	$-5.0M	$-3.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-1.49
FCF Yield	-215.52%
Quick Ratio	0.06
Interest Coverage	-7.69
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AVGRAvinger, Inc.	$0.47	-20.74%	-0.02	$1.52M	0.00%
AXDXAccelerate Diagnostics, Inc.	$0.03	+0.00%	-0.02	$859918	0.00%
CMAXCareMax, Inc.	$0.42	+100.00%	0.00	$1.61M	0.00%
CUTRCutera, Inc.	$0.10	+0.00%	-0.01	$1.96M	0.00%
NBSENeuBase Therapeutics, Inc.	$0.38	-1.56%	-0.02	$1.42M	0.00%

About NAYA Biosciences, Inc.

NAYA Biosciences, Inc. is headquartered in US.

NAYA Biosciences, Inc. (NAYA) stock trades at $2.20 with a market capitalization of $1.47M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.07, reflecting a net loss over the last twelve months, price-to-book of 0.05, price-to-sales of 0.22. Over the past 52 weeks the stock has ranged between $1.38 and $17.04, and currently trades 87.1% below its 52-week high.

On profitability, NAYA Biosciences, Inc. generates a return on equity (ROE) of -133.37% (negative, reflecting a net loss), return on capital employed of -28.49%, an operating margin of -124.40%, a net profit margin of -139.25%.

Official website: www.nayabiosciences.com